Enrique A. Conterno
Senior Vice President and President, Lilly Diabetes and Lilly USA
Twitter: @LillyPad
Since the breakthrough discovery of insulin in the early 20th Century, diabetes has transformed from a deadly disease to a chronic but manageable condition. Innovations in science – leading to more effective insulins – and technological advances allowing for better monitoring have enabled people living with diabetes to more closely monitor their health.
At Lilly, we are dedicated to developing medicines for unmet needs, particularly for people facing barriers to accessing care and managing their conditions under the traditional in-office care model.